In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: Alteration of primary adaptive responses

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 4495-4506

  Winkler Pickett, Robin ^a   Young, Howard A ^a,d   Cherry, James M ^b   Diehl, John ^b   Wine, John ^a   Back, Timothy ^a   Bere, William E ^c   Mason, Anna T ^a   Ortaldo, John R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^c SAIC FREDERICK INC   (United States)

^d Laboratory of Experimental Immunology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; T CELL RECEPTOR VBETA; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG; KILLER CELL LECTIN LIKE RECEPTOR, SUBFAMILY A; KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY A; LECTIN; LY ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MYELIN ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNIZATION; LYMPH NODE; LYMPHOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ADAPTATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIGENS, LY; CELLS, CULTURED; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; MYELIN-ASSOCIATED GLYCOPROTEIN; RECEPTORS, ANTIGEN, T-CELL;

EID: 44449127680     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.4495     Document Type: Article

References (73)

1. Biron, C. A., K. B. Nguyen, and G. C. Pien. 2002. Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 263: 7-27.
2. Tay, C. H., E. Szomolanyi-Tsuda, and R. M. Welsh. 1998. Control of infections by NK cells. Curr. Top. Microbiol. Immunol. 230: 193-220.
3. + T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-γ production. J. Exp. Med. 204: 2591-2602.
4. Moretta, A., E. Marcenaro, S. Parolini, G. Ferlazzo, and L. Moretta. 2008. NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 15: 226 -233.
5. Walzer, T., M. Dalod, E. Vivier, and L. Zitvogel. 2005. Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin. Biol. Ther. 5(Suppl. 1): S49-S59.
6. Makarenkova, V., A. K. Chakrabarti, J. A. Liberatore, P. Popovic, G. Lu, S. Watkins, and N. L. Vujanovic. 2005. Dendritic cells and natural killer cells interact via multiple TNF family molecules. J. Leukocyte Biol. 77: 408 -413.
7. Mor, F., F. Quintana, A. Mimran, and I. R. Cohen. 2003. Autoimmune encephalomyelitis and uveitis induced by T cell immunity to self β-synuclein. J. Immunol. 170: 628 -634.
8. Playfair, J. H., and S. Marshall-Clarke. 1973. Induction of red cell autoantibodies in normal mice. Nat. New Biol. 243: 213-214.
9. Radford-Smith, G. 1997. Ulcerative colitis: an immunological disease? Baillieres Clin. Gastroenterol. 11: 35-52.
10. Mountz, J. D., W. C. Gause, and R. Jonsson. 1991. Murine models for systemic lupus erythematosus and Sjogren's syndrome. Curr. Opin. Rheumatol. 3:738 -756.
11. Samuels, J., Y. S. Ng, C. Coupillaud, D. Paget, and E. Meffre. 2005. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 201:1659 -1667.
12. Huang, S. W., J. W. Rose, and R. F. Mayer. 1977. Assessment of cellular and humoral immunity of myasthenics. J. Neurol. Neurosurg. Psychiatry 40:1053-1059.
13. Flodstrom, M., A. Maday, D. Balakrishna, M. M. Cleary, A. Yoshimura, and N. Sarvetnick. 2002. Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 3: 373-382.
14. Poirot, L., C. Benoist, and D. Mathis. 2004. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc. Natl. Acad. Sci. USA 101: 8102-8107.
15. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 173: 6418 -6426.
16. Alvord, E. C., Jr. 1984. Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis. Liss, New York.
17. Tabira, T., and J. Kira. 1992. Strain and species differences of encephalitogenic determinants of myelin basic protein and proteolipid apoprotein. In Myelin: Biology and Chemistry. R. E. Martenson, ed. CRC, Boca Raton, FL, pp. 783-800.
18. Merrill, J. E., and E. N. Benveniste. 1996. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19: 331-338.
19. + T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178: 909-916.
20. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
21. Zhang, B., T. Yamamura, T. Kondo, M. Fujiwara, and T. Tabira. 1997. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186: 1677-1687.
22. Matsumoto, Y., K. Kohyama, Y. Aikawa, T. Shin, Y. Kawazoe, Y. Suzuki, and N. Tanuma. 1998. Role of natural killer cells and TCR γδ T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28: 1681-1688.
23. + T cells in a transfer model of colitis. J. Immunol. 161:3256-3261.
24. Lehuen, A., O. Lantz, L. Beaudoin, V. Laloux, C. Carnaud, A. Bendelac, J. F. Bach, and R. C. Monteiro. 1998. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188: 1831-1839.
25. Shi, F., H. G. Ljunggren, and N. Sarvetnick. 2001. Innate immunity and auto- immunity: from self-protection to self-destruction. Trends Immunol. 22: 97-101.
26. Shi, F. D., H. B. Wang, H. Li, S. Hong, M. Taniguchi, H. Link, L. Van Kaer, and H. G. Ljunggren. 2000. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat. Immunol. 1: 245-251.
27. Shi, F. D., K. Takeda, S. Akira, N. Sarvetnick, and H. G. Ljunggren. 2000. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-γ by NK cells. J. Immunol. 165: 3099-3104.
28. Huang, D., F. D. Shi, S. Jung, G. C. Pien, J. Wang, T. P. Salazar-Mather, T. T. He, J. T. Weaver, H. G. Ljunggren, C. A. Biron, et al. 2006. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20: 896-905.
29. Ortaldo, J. R., R. Winkler-Pickett, and G. Wiegand. 2000. Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors. J. Leukocyte Biol. 68: 748 -756.
30. Gussoni, E., M. A. Panzara, and L. Steinman. 2003. Evaluating human T cell receptor gene expression by PCR. In Current Protocols in Immunology. J. Coligan, Ed. Wiley, New York, pp. 10.26.1-10.26.14.
31. b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 25: 1951-1959.
32. + T cells. Science 248: 1227-1230.
33. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
34. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259: 1739-1742.
35. + T cells. J. Immunol. 166: 4209-4215.
36. Xu, W., G. Fazekas, H. Hara, and T. Tabira. 2005. Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis. J. Neu- roimmunol. 163: 24-30.
37. Ortaldo, J. R., L. H. Mason, T. A. Gregorio, J. Stoll, and R. T. Winkler-Pickett. 1997. The Ly-49 family: regulation of cytokine production in murine NK cells. J. Leukocyte Biol. 62: 381-388.
38. Ortaldo, J. R., R. Winkler-Pickett, J. Willette-Brown, R. L. Wange, S. K. Anderson, G. J. Palumbo, L. H. Mason, and D. W. McVicar. 1999. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors. J. Immunol. 163: 5269-5277.
39. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566 -573.
40. Furuzawa-Carballeda, J., M. I. Vargas-Rojas, and A. R. Cabral. 2007. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6: 169-175.
41. Suryani, S., and I. Sutton. 2007. An interferon-γ-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis. J. Neuroimmu-nol. 183: 96-103.
42. H1 priming. Nat. Immunol. 5: 1260-1265.
43. Mendel, I., N. Kerlero de Rosbo, and A. Ben-Nun. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune en- cephalomyelitis in H-2b mice: fine specificity and T cell receptor V β expression of encephalitogenic T cells. Eur. J. Immunol. 25: 1951-1959.
44. Mendel, I., N. Kerlero de Rosbo, and A. Ben-Nun. 1996. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V β gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V β and T cell receptor V β H-2b mice. Eur. J. Immunol. 26: 2470-2479.
45. Zhong, M. C., L. Cohen, A. Meshorer, N. Kerlero de Rosbo, and A. Ben-Nun. 2000. T cells specific for soluble recombinant oligodendrocyte-specific protein induce severe clinical experimental autoimmune encephalomyelitis in H-2(b) and H-2(s) mice. J. Neuroimmunol. 105: 39-45.
46. Mendel, I., A. Katz, N. Kozak, A. Ben-Nun, and M. Revel. 1998. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28: 1727-1737.
47. b mice. Eur. J. Immunol. 26: 2470-2479.
48. Raulet, D. H. 2004. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5: 996 -1002.
49. Yokoyama, W. M. 2005. Specific and non-specific natural killer cell responses to viral infection. Adv. Exp. Med. Biol. 560: 57-61.
50. Zingoni, A., T. Sornasse, B. G. Cocks, Y. Tanaka, A. Santoni, and L. L. Lanier. 2005. NK cell regulation of T cell-mediated responses. Mol. Immunol. 42:451-454.
51. - regulatory T cells and T cell clones presenting TCR pep- tide: its implication for TCR vaccination against experimental autoimmune en- cephalomyelitis. J. Immunol. 157: 1781-1790.
52. + cytolytic T cells by suppressing or eliminating dendritic cells. J. Immunol. 136: 3567-3571.
53. Yohe, H. C., S. Ye, B. B. Reinhold, and V. N. Reinhold. 1997. Structural characterization of the disialogangliosides of murine peritoneal macrophages. Glyco- biology 7: 1215-1227.
54. + central memory-type T cells as precursor cells for interferon-γ-producing killer T cells. Cancer Sci. 97: 1236-1241.
55. Takeda, K., and G. Dennert. 1993. The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-pos-itive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J. Exp. Med. 177: 155-164.
56. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182: 1045-1056.
57. Wilder, J. A., C. Y. Koh, andD. Yuan. 1996. The role of NK cells during in vivo antigen-specific antibody responses. J. Immunol. 156: 146-152.
58. Bix,M.,andR.M. Locksley. 1995. NaturalTcells: cellsthatco-expressNKRP-1 and TCR. J. Immunol. 155: 1020-1022.
59. + T cells. Curr. Opin. Immunol. 7: 367-374.
60. + NK T cells: a novel lymphoid cell lineage with regulatory function. J. Allergy Clin. Immunol. 98: S263-S269.
61. Yoshimoto, T., and W. E. Paul. 1994. CD4pos, NK1.1pos T cells promptly pro-duce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179: 1285-1295.
62. Farag, S. S., J. B. VanDeusen, T. A. Fehniger, and M. A. Caligiuri. 2003. Biology and clinical impact of human natural killer cells. Int. J. Hematol. 78: 7-17.
63. Tay, C. H.,L. Y. Yu,V. Kumar, L. Mason,J. R. Ortaldo,andR. M. Welsh. 1999. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J. Immunol. 162: 718 -726.
64. Shi, F. D., and K. L. Van. 2006. Reciprocal regulation between natural killer cells and autoreactive T cells. Nat. Rev. Immunol. 6: 751-760.
65. Romagnani, S. 1992. Induction of TH1 and TH2 responses: a key role for the "natural" immune response? Immunol. Today 13: 379-381.
66. Fearon, D. T., andR. M. Locksley. 1996. Theinstructiveroleofinnateimmunity in the acquired immune response. Science 272: 50 -53.
67. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376.
68. Ortaldo, J. R., and H. A. Young. 2003. Expression of IFN-γ upon triggering of activating Ly49D NK receptors in vitro and in vivo: costimulation with IL-12 or IL-18 overrides inhibitory receptors. J. Immunol. 170: 1763-1769.
69. Bakker, A. B., R. M. Hoek, A. Cerwenka, B. Blom, L. Lucian, T. McNeil, R. Murray, L. H. Phillips, J. D. Sedgwick, and L. L. Lanier. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13: 345-353.
70. Ortaldo, J. R., and R. B. Herberman. 1984. Heterogeneity of natural killer cells. Annu. Rev. Immunol. 2: 359 -394.
71. Smith, K. A., J. Wu, A. B. H. Bakker, J. H. Phillips, and L. L. Lanier. 1998. Ly49D and Ly49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161: 7-10.
72. Dokun, A. O., S. Kim, H. R. Smith, H. S. Kang, D. T. Chu, and W. M. Yokoyama. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2: 951-956.
73. Ortaldo, J. R., E. W. Bere, D. Hodge, and H. A. Young. 2001. Activating Ly-49 NK receptors: central role in cytokine and chemokine production. J. Immunol. 166: 4994-4999.